You are here

Medical Testing

FDA new guidance: Vaccines Adapted for Variants Will Not Need Lengthy Testing

The Food and Drug Administration said on Monday that vaccine developers would not need to conduct lengthy randomized controlled trials for vaccines that have been adapted to protect against concerning coronavirus variants.

The recommendations, which call for small trials more like those required for annual flu vaccines, would greatly accelerate the review process at a time when scientists are increasingly anxious about how the variants might slow or reverse progress made against the virus.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

The difficulties in enrolling teenagers for vaccine test trials.

 

 

Teenagers contract the novel coronavirus almost twice as often as younger children but vaccines authorized in the United States are mostly for adults — Moderna’s for 18 and older, Pfizer’s for 16 and up.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Medical Testing
howdy folks
Page loaded in 0.546 seconds.